The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Abstract
BACKGROUND.: Venous thromboembolism (VTE) contributes to morbidity and mortality in cancer patients and is a frequent complication of anticancer therapy. In the current study, the frequency, risk factors, and trends associated with VTE were examined among hospitalized cancer patients. METHODS.: A retrospective cohort study was conducted using the discharge database of the University HealthSystem Consortium. This included 1,824,316 hospitalizations between 1995 and 2003 at 133 U.S. medical centers. RESULTS.: Among 1,015,598 cancer patients, 34,357 (3.4%) were diagnosed with deep venous thrombosis and 11,515 with pulmonary embolism (PE) (1.1%) for an overall VTE rate of 4.1%. Subgroups of cancer patients with the highest rates included black ethnicity (5.1% per hospitalization) and those receiving chemotherapy (4.9%). Sites of cancer with the highest rates of VTE included pancreas (8.1%), kidney (5.6%), ovary (5.6%), lung (5.1%), and stomach (4.9%). Among hematologic malignancies, myeloma (5%), non‐Hodgkin lymphoma (4.8%), and Hodgkin disease (4.6%) had the highest rates of VTE. The rate of VTE increased by 28%, secondary to a near‐doubling of PE rates from 0.8% to 1.5% (P < .0001). Among patients receiving chemotherapy, the rates of VTE rose from 3.9% to 5.7%, an increase of 47% (P < .0001). In multivariate analysis, risk factors associated with VTE included age ≥65 years, female sex, black ethnicity, use of chemotherapy, primary site of cancer, presence of comorbidities, and year of admission. CONCLUSIONS.: VTE, particularly PE, is an increasingly frequent complication of hospitalization in cancer patients. Patients with black ethnicity, specific sites of cancer, or those receiving chemotherapy are disproportionately at risk. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Agresti, A. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/0471249688 · Cited by 6,746
Prevention of Venous Thromboembolism
Geerts, W. H., Pineo, G. F., Heit, J. A., Bergqvist, D., Lassen, M. R., Colwell, C. W., & Ray, J. G. (2004) · Chest · doi:10.1378/chest.126.3_suppl.338s · Cited by 5,895
Silverstein, M. D., Heit, J. A., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.585 · Cited by 2,660
Risk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Prandoni, P., Lensing, A. W. A., Piccioli, A., Bernardi, E., Simioni, P., Girolami, B., Marchiori, A., Sabbion, P., Prins, M. H., Noventa, F., et al. (2002) · Blood · doi:10.1182/blood-2002-01-0108 · Cited by 1,863
Kabbinavar, F., Hurwitz, H. I., Fehrenbacher, L., Meropol, N. J., Novotny, W. F., Lieberman, G., Griffing, S., & Bergsland, E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.066 · Cited by 1,716
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
KHORANA, A. A., FRANCIS, C. W., CULAKOVA, E., KUDERER, N. M., & LYMAN, G. H. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02374.x · Cited by 1,670
Self-citationPrognosis of Cancers Associated with Venous Thromboembolism
Sørensen, H. T., Mellemkjær, L., Olsen, J. H., & Baron, J. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012213432504 · Cited by 1,628
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. R. (2006) · Archives of Internal Medicine · doi:10.1001/.458 · Cited by 1,321
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
BLOM, J. W., VANDERSCHOOT, J. P. M., OOSTINDIËR, M. J., OSANTO, S., VAN DER MEER, F. J. M., & ROSENDAAL, F. R. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01804.x · Cited by 692
Incidence and Time Course of Thromboembolic Outcomes Following Total Hip or Knee Arthroplasty
White, R. H., Romano, P. S., Zhou, H., Rodrigo, J., & Bargar, W. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.14.1525 · Cited by 588
Validity of Information on Comorbidity Derived From ICD-9-CCM Administrative Data
Quan, H., Parsons, G. A., & Ghali, W. A. (2002) · Medical Care · doi:10.1097/00005650-200208000-00007 · Cited by 579
Incidence of Venous Thromboembolism in Patients Hospitalized with Cancer
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., Sanchez, J., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.058 · Cited by 566
Risk factors for chemotherapy‐associated venous thromboembolism in a prospective observational study
Khorana, A. A., Francis, C. W., Culakova, E., & Lyman, G. H. (2005) · Cancer · doi:10.1002/cncr.21496 · Cited by 565
Self-citationThe Epidemiology of Diagnosed Pulmonary Embolism and Deep Venous Thrombosis in the Elderly
Kniffin, W. D. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.8.861 · Cited by 529
Thromboembolism in Hospitalized Neutropenic Cancer Patients
Khorana, A. A., Francis, C. W., Culakova, E., Fisher, R. I., Kuderer, N. M., & Lyman, G. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.8877 · Cited by 475
Self-citationThe Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer
Levine, M. N., Gent, M., Hirsh, J., Arnold, A., Goodyear, M. D., Hryniuk, W., & De Pauw, S. (1988) · New England Journal of Medicine · doi:10.1056/nejm198802183180703 · Cited by 412
Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics
Wan, J., Nguyen, N., & Sallah, S. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613051 · Cited by 411
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer.
Saphner, T., Tormey, D. C., & Gray, R. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.2.286 · Cited by 396
Zhou, H., Murin, S., Harvey, D., & White, R. H. (2005) · Thrombosis and Haemostasis · doi:10.1160/th04-08-0506 · Cited by 295
Kahn, S. R., Panju, A., Geerts, W., Pineo, G. F., Desjardins, L., Turpie, A. G. G., Glezer, S., Thabane, L., & Sebaldt, R. J. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2006.01.011 · Cited by 284
Outcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
Elting, L. S., Escalante, C. P., Cooksley, C., Avritscher, E. B. C., Kurtin, D., Hamblin, L., Khosla, S. G., & Rivera, E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1653 · Cited by 269
Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey
Kakkar, A. K., Levine, M., Pinedo, H. M., Wolff, R., & Wong, J. (2003) · The Oncologist · doi:10.1634/theoncologist.8-4-381 · Cited by 207
Prophylaxis for Thromboembolism in Hospitalized Medical Patients
Francis, C. W. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp067264 · Cited by 195
Self-citationAccuracy of coding for possible warfarin complications in hospital discharge abstracts
Arnason, T., Wells, P. S., van Walraven, C., & Forster, A. J. (2006) · Thrombosis Research · doi:10.1016/j.thromres.2005.06.015 · Cited by 192
Malignancy, thrombosis and Trousseau: the case for an eponym
Khorana, A. A. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2003.00501.x · Cited by 166
Self-citationCavo, M., Zamagni, E., Cellini, C., Tosi, P., Cangini, D., Cini, M., Valdré, L., Palareti, G., Masini, L., Tura, S., et al. (2002) · Blood · doi:10.1182/blood-2002-06-1674 · Cited by 152
_, _. (2006) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2006.0071 · Cited by 97
Multidetector Computed Tomography Technology
Kalra, M. K., Maher, M. M., D’Souza, R. V., & Saini, S. (2004) · Journal of Computer Assisted Tomography · doi:10.1097/01.rct.0000120857.80935.bd · Cited by 91
Risk factors for venous thrombosis in the black population
Patel, R. K. P., Ford, E., Thumpston, J., & Arya, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-05-0311 · Cited by 69
Cited by
Epidemiology of cancer-associated venous thrombosis
Timp, J. F., Braekkan, S. K., Versteeg, H. H., & Cannegieter, S. C. (2013) · Blood · doi:10.1182/blood-2013-04-460121 · Cited by 1,205
Lyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Self-citationPrediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
Venous thromboembolism in cancer patients: a population-based cohort study
Mulder, F. I., Horváth-Puhó, E., van Es, N., van Laarhoven, H. W. M., Pedersen, L., Moik, F., Ay, C., Büller, H. R., & Sørensen, H. T. (2021) · Blood · doi:10.1182/blood.2020007338 · Cited by 723
Lyman, G. H., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., Gates, L. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1118 · Cited by 713
Self-citation
Metadata
- Authors
- Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-10-04
- Volume
- 110
- Issue
- 10
- Pages
- 2339-2346
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1995935980
- Cited by
- 781
- References
- 31
- FWCI
- 17.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.